GlassScriptPhysician profile
Karin Young
NPI 1902290323
$3,695.73
in general payments reported to CMS, 2019-2025
15 companies · $955 in 2025
The $955 reported for 2025 was more than what 95% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.28 · 2022: $588 · 2023: $1,132 · 2024: $987 · 2025: $955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,029 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,029.38 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $2,268.26 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $514.00 | 2022 | |
| Sage Therapeutics, LLC | $208.79 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $157.77 | 2023-2025 | Veozah |
| Lilly USA, LLC | $96.89 | 2023-2025 | Zepbound, Mounjaro, Trulicity |
| Abbvie INC. | $91.31 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.74 | 2021-2023 | |
| Organon LLC | $52.53 | 2025 | Nexplanon |
| Hologic Sales and Service, LLC | $42.37 | 2022-2023 | Acessa Provu System |
| Agile Therapeutics, INC. | $42.25 | 2021-2023 | Twirla |
| Millicent US INC | $40.61 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Smith+Nephew, INC. | $26.95 | 2023 | Stravix |
| Ethicon US, LLC | $24.46 | 2023 | Dermabond Prineo |
| Vertex Pharmaceuticals Incorporated | $21.86 | 2024 | |
| Pfizer INC. | $19.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karin Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.